Bob Fabbio is widely recognized as a visionary and serial entrepreneur. He was appointed as CEO after joining Welltok in mid-2019 as chief operating officer. Fabbio has previously functioned as a chief executive officer, board director and venture capitalist for over 30 years, with notable experience launching, growing and operating innovative, category-creating companies. He has had a transformational impact on the software, systems technology and healthcare industries, resulting in the creation of over $1.5 billion of shareholder value at time of exit.
Prior to Welltok, he was CEO of multiple middleware and SaaS healthcare IT companies including eRelevance Corporation, WhiteGlove Health, Tivoli Systems (acquired by IBM) and DAZEL Corporation (acquired by HP). He previously served as a venture partner for Austin Ventures and a Managing Director of TL Ventures Inc. where he was on a number of boards, including the active chairman of Agere Systems. He is also a partner at startup incubator Capital Factory helping young companies crystallize their business and propelling them to the next levels of success.